Unconfigured Ad
Collapse
New here? Stop in and introduce yourself. Where you are, what you work on, etc.
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by ECO, 11-21-2011, 08:25 PM
|
16 responses
55,215 views
0 reactions
|
Last Post
by plant_hunt
11-06-2019, 05:43 AM
|
||
|
Started by EMeyer, 07-16-2008, 04:49 PM
|
0 responses
2,217 views
0 reactions
|
Last Post
by EMeyer
07-16-2008, 04:49 PM
|
||
|
Started by akka9981, 07-10-2008, 06:43 PM
|
0 responses
2,665 views
0 reactions
|
Last Post
by akka9981
07-10-2008, 06:43 PM
|
||
|
Started by cocomilk, 07-07-2008, 06:47 AM
|
6 responses
2,760 views
0 reactions
|
Last Post
by cocomilk
07-10-2008, 10:28 AM
|
||
|
Started by alim, 06-22-2008, 10:32 AM
|
1 response
2,458 views
0 reactions
|
Last Post
by apfejes
07-10-2008, 09:48 AM
|
||
|
Started by tjahns, 07-10-2008, 01:32 AM
|
0 responses
2,498 views
0 reactions
|
Last Post
by tjahns
07-10-2008, 01:32 AM
|
||
|
Started by wesb, 07-09-2008, 12:00 PM
|
0 responses
3,623 views
0 reactions
|
Last Post
by wesb
07-09-2008, 12:00 PM
|
||
|
Started by warindrarto, 07-01-2008, 02:14 AM
|
0 responses
2,163 views
0 reactions
|
Last Post
by warindrarto
07-01-2008, 02:14 AM
|
||
|
Started by tlitman, 06-24-2008, 11:09 AM
|
3 responses
3,329 views
0 reactions
|
Last Post
by Chipper
06-24-2008, 02:13 PM
|
||
|
Started by Patrik, 06-15-2008, 09:42 PM
|
0 responses
2,432 views
0 reactions
|
Last Post
by Patrik
06-15-2008, 09:42 PM
|
||
|
Started by sequencer_lee, 05-23-2008, 10:34 AM
|
0 responses
2,703 views
0 reactions
|
Last Post
|
No topics found.
-
Page of 0
No photos found.
-
Page of 0
Webinars
Collapse
-
by SEQadmin2
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...-
Channel: Webinar Series
07-31-2026, 07:00 AM -
Recent Articles
Collapse
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 08-20-2026, 11:17 AM
|
0 responses
13 views
0 reactions
|
Last Post
by SEQadmin2
08-20-2026, 11:17 AM
|
||
|
Started by SEQadmin2, 08-18-2026, 10:05 AM
|
0 responses
21 views
0 reactions
|
Last Post
by SEQadmin2
08-18-2026, 10:05 AM
|
||
|
Started by SEQadmin2, 08-13-2026, 12:22 PM
|
0 responses
42 views
0 reactions
|
Last Post
by SEQadmin2
08-13-2026, 12:22 PM
|